HIGH-RISK NEUROBLASTOMA
Clinical trials for HIGH-RISK NEUROBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new HIGH-RISK NEUROBLASTOMA trials appear
Sign up with your email to follow new studies for HIGH-RISK NEUROBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough cancer: drug combo trial launches
Disease control Not yet recruitingThis study tests whether adding the drug naxitamab to standard chemotherapy is safe and effective for children and young adults (ages 1 to 21) newly diagnosed with high-risk neuroblastoma, an aggressive nerve cancer. Ten participants will receive the combination during initial tr…
Matched conditions: HIGH-RISK NEUROBLASTOMA
Phase: PHASE2 • Sponsor: Shaare Zedek Medical Center • Aim: Disease control
Last updated May 17, 2026 03:19 UTC
-
New scan could improve detection of childhood nerve cancer
Diagnosis Not yet recruitingThis study tests whether a new type of scan (18F-MFBG PET/CT or PET/MRI) can find neuroblastoma tumors as well as the current standard scan (123I-MIBG). About 84 children and adults with newly diagnosed, high-risk neuroblastoma will receive both scans at different times. The goal…
Matched conditions: HIGH-RISK NEUROBLASTOMA
Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Diagnosis
Last updated May 13, 2026 16:03 UTC